FBMJ pharmacist attorney, Kim Sveska, recently published the article “FDA Changes Direction Regarding Compounded Drugs” in the Michigan Pharmacist Journal (2022 Vol. 60 Issue 2), a publication of the Michigan
FBMJ attorneys Julie Janeway and Brian Whitelaw co-authored, “7 Legal Risks of Promoting Unproven COVID Treatments,” published by Medscape on December 6, 2021. The article cautions healthcare providers of the risks
The Michigan Marijuana Regulatory Agency (“MRA”) periodically updates the administrative rules that impact licensed cannabis operations. On September 27, 2021, the MRA held a public hearing with respect to proposed
FBMJ attorneys, Saulius Polteraitis and Carlos Escurel, recently presented “Covid Liability and Impact Medical Malpractice Claims” to the Michigan Society of Healthcare Risk Managers (MSHRM) as part of its Webinar
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.